Clinical Trials Directory

Trials / Unknown

UnknownNCT06229509

Study of the Cytokine Response During Exercise Dyspnea in Patients With Chronic Obstructive Pulmonary Disease (COPD). Effect of Body Composition

Study of Cytokine Response During Exercise Dyspnea in Patients With Chronic Obstructive Pulmonary Disease (COPD). Effect of Body Composition

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
26 (estimated)
Sponsor
University Hospital, Clermont-Ferrand · Academic / Other
Sex
Male
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

Dyspnea, more commonly known as breathlessness, is a symptom found in the majority of patients with chronic obstructive pulmonary disease (COPD), with a major impact on quality of life and mortality. COPD is a chronic inflammatory disease of the bronchi, affecting 8% of the French population (more than 3 million people). By 2030, it will be the third leading cause of death worldwide. Effective management of dyspnea in these patients is a priority. In patients with severe COPD, physical exertion increases the workload of breathing, leading to dyspnea. At the same time, the respiratory muscles and fatty cells release cytokines, myokines and adipokines - a group of proteins involved in the inflammatory response. In addition, 15% of COPD patients suffer from sarcopenia (loss of muscle mass and strength) which increases respiratory effort and dyspnea. Our research project aims to study the effect of dyspnea relief in COPD patients on cytokine, myokine and adipokine levels, taking into account the presence of sarcopenia. Indeed, it is possible to alleviate the workload of the respiratory muscles during exercise by means of respiratory assistance. The ultimate goal is a better understanding of dyspnea mechanisms, to enable the development of cytokine-targeted therapies and improve quality of life and survival in these patients.

Conditions

Interventions

TypeNameDescription
DEVICEEffective noninvasive ventilationNoninvasive ventilation set to alleviate dyspnea Inspiratory aid set according to a preliminary test (aiming for a diminution of 2 points in Borg score)
DEVICESham noninvasive ventilationNoninvasive ventilation set with an insufficient inspiratory aid to alleviate dyspnea

Timeline

Start date
2024-02-01
Primary completion
2024-08-01
Completion
2024-08-01
First posted
2024-01-29
Last updated
2024-01-29

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06229509. Inclusion in this directory is not an endorsement.